Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.

Califf RM, Woodlief LH, Harrell FE, Lee KL, White HD, Guerci A, Barbash GI, Simes RJ, Weaver WD, Simoons ML, Topol EJ
Am Heart J. 1997 133 (6): 630-9

PMID: 9200390 · DOI:10.1016/s0002-8703(97)70164-9

MeSH Terms (23)

Aged Age Factors Anticoagulants Blood Pressure Fibrinolytic Agents Forecasting Heart Rate Heparin Humans Injections, Intravenous Injections, Subcutaneous Logistic Models Middle Aged Models, Statistical Myocardial Infarction Plasminogen Activators Prognosis Risk Factors Streptokinase Survival Rate Thrombolytic Therapy Tissue Plasminogen Activator Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: